SCHEMBL7258289

SCHEMBL7258289

O=S(=O)(O)Nc1ccc(N2CCN(Cc3cc4ccccc4o3)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 9/20 0.54
HTR1A P08908 7/20 0.54
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
DRD2 P14416 10/20 0.50
DRD3 P35462 3/20 0.50
DRD1 P21728 2/20 0.50
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
DRD5 P21918 1/20 0.47
DRD4 P21917 1/20 0.47
HTR2A P28223 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7258263 0.80 KMT2A (0.52) DRD2NPC1RAB9AKMT2AMEN1
SCHEMBL7263869 0.79 ALDH1A1 (0.46) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL7258434 0.77 GFER (0.54) DRD2DRD3KMT2AMEN1DRD4
SCHEMBL22113447 0.77 HTR2B (0.78) HTR2BHTR1ADRD2KMT2AMEN1
SCHEMBL2626009 0.76 HTR2B (0.44) HTR2BHTR1ACA2CA9DRD2
SCHEMBL7262647 0.75 LMNA (0.56) CA2CA9NPC1RAB9AKMT2A
SCHEMBL7262362 0.74 DRD4 (0.64) DRD2DRD3DRD1NPC1RAB9A
SCHEMBL7258467 0.73 KMT2A (0.50) CA2KMT2AMEN1KDM4EALDH1A1
SCHEMBL7258839 0.73 ALDH1A1 (0.62) DRD2DRD4KDM4EALDH1A1LMNA
SCHEMBL7262997 0.73 ALDH1A1 (0.51) KMT2AMEN1KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003082263-A1 SULFAMIC ACIDS AS INHIBITORS OF HUMAN CYTOPLASMIC PROTEIN TYROSINE PHOSPHATASES ONTOGEN CORPORATION (US) 2003-10-09 WO disclosed